Clinical Trial Update: A Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Volunteers With Varying Degrees of Kidney Function [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics, pharmacodynamics, and safety of canagliflozin across varying kidney function, including individuals with renal in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• Canagliflozin (canagliflozin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Renal Insufficiency, Healthy | Phase 1 | Status: COMPLETED